Appl Health Econ Health Policy
July 2009
Background: An ongoing debate exists about whether the US should adopt a universal health insurance programme. Much of the debate has focused on programme implementation and cost, with relatively little attention to benefits for social welfare.
Objective: To estimate the effect on US population health outcomes, measured by mortality, of extending private health insurance to the uninsured, and to obtain a rough estimate of the aggregate economic benefits of extending insurance coverage to the uninsured.
Objective: To determine the utility of simple patient-reported information in signalling erectile dysfunction (ED), as a challenge for the clinical urologist or related specialist is to quickly recognize risk factors for sexual dysfunction within the time constraints of an office visit.
Patients And Methods: In a sample of men visiting a urology clinic, we determined the utility of simple patient-reported information in signalling ED.
Results: Information readily obtained through a patient's self-report (that typically obtained in the office setting) can be very useful in understanding and predicting the likelihood of ED.
As the study of human sexual response becomes increasingly complex to meet the demands of this interdisciplinary field, the need for appropriate analytical tools has grown as well. In this review, we attempt to familiarize sexologists with the wide range of applications of regression analysis to the study of human sexual response. To this end, a typical experiment in human sexual response is described, and the basic regression model for the experiment is provided.
View Article and Find Full Text PDFPsychopharmacology (Berl)
September 2002
Rationale: Changes in dopamine level are thought to play an important role in both smoking reward and withdrawal symptoms during abstinence. Medications that modulate dopamine levels may have beneficial effects on both withdrawal symptom levels and on response to smoking lapses during abstinence.
Objectives: To examine the effects of the selective MAO-B inhibitor selegiline on withdrawal symptoms, smoking behavior and smoking satisfaction ratings.